Skip to content

NAVIDEA BIOPHARMACEUTICALS, INC.: filings

Every NAVIDEA BIOPHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filing record ends 2023-11-14

The latest filing in this captured record is a 10-Q filed 2023-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. NAVIDEA BIOPHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-14fiscal Q3 2023431200001437749-23-032052
10-Q2023-08-11fiscal Q2 2023441180001437749-23-023319
10-Q2023-05-11fiscal Q1 202339790001437749-23-013972
10-K2023-03-27fiscal FY 202247940001437749-23-008054
10-Q2022-11-14fiscal Q3 2022461310001437749-22-027321
10-Q2022-08-15fiscal Q2 2022431170001437749-22-020558
10-Q2022-05-16fiscal Q1 202243870001437749-22-012668
10-K2022-03-28fiscal FY 202144890001437749-22-007390
10-Q2021-11-12fiscal Q3 2021431230001437749-21-026457
10-Q2021-08-12fiscal Q2 2021411110001437749-21-019756
10-Q2021-05-13fiscal Q1 202141840001437749-21-012043
10-K2021-03-26fiscal FY 202044920001437749-21-007329
10-Q2020-11-13fiscal Q3 2020411150001437749-20-023829
10-Q2020-08-14fiscal Q2 2020411120001437749-20-018032
10-Q2020-05-15fiscal Q1 202042860001437749-20-010995
10-K2020-03-18fiscal FY 201944900001437749-20-005567
10-Q2019-11-08fiscal Q3 2019431200001437749-19-022151
10-Q2019-08-09fiscal Q2 2019441180001437749-19-016235
10-Q2019-05-09fiscal Q1 201944890001437749-19-009295
10-K2019-03-15fiscal FY 201846940001437749-19-005086
10-Q2018-11-09fiscal Q3 2018451230001437749-18-020274
10-Q2018-08-08fiscal Q2 2018451220001437749-18-014956
10-Q2018-05-09fiscal Q1 201843840001437749-18-009223
10-K2018-03-15fiscal FY 2017451650001437749-18-004756
10-Q2017-11-09fiscal Q3 2017431130001437749-17-018892
10-Q2017-08-09fiscal Q2 2017431160001437749-17-014271
10-Q2017-05-10fiscal Q1 201741820001654954-17-004355
10-K2017-03-31fiscal FY 2016371260001654954-17-002915
10-Q2016-11-09fiscal Q3 201634900001564590-16-028688
10-Q2016-08-11fiscal Q2 201634880001564590-16-024057
10-Q2016-05-16fiscal Q1 201635700001564590-16-019588
10-K2016-03-23fiscal FY 2015361200001564590-16-015173
10-Q2015-11-09fiscal Q3 201537920001564590-15-010204
10-Q2015-08-10fiscal Q2 2015401020000810509-15-000008
10-Q2015-05-11fiscal Q1 201540800000810509-15-000005
10-K2015-03-16fiscal FY 2014421450000810509-15-000003
10-Q2014-11-10fiscal Q3 2014391020000810509-14-000009
10-Q2014-08-11fiscal Q2 2014391020000810509-14-000006
10-Q2014-05-09fiscal Q1 201439800001445305-14-002058
10-K2014-03-14fiscal FY 2013421450001445305-14-001051
10-Q2013-11-12fiscal Q3 2013401070001445305-13-002940
10-Q2013-08-09fiscal Q2 2013391030001144204-13-044329
10-Q2013-05-10fiscal Q1 201338770001144204-13-027688
10-K/A2013-03-21fiscal FY 2012411060001144204-13-016705
10-Q2012-11-13fiscal Q3 2012391010001144204-12-061296
10-Q2012-08-09fiscal Q2 2012391000001144204-12-044168
10-Q2012-05-10fiscal Q1 201237730001144204-12-027592
10-K2012-03-07fiscal FY 2011391020001144204-12-013346
10-Q2011-11-09fiscal Q3 201138960001144204-11-062335
10-Q2011-08-08fiscal Q2 2011391000001144204-11-044610

Inspect the source

Entity
NAVIDEA BIOPHARMACEUTICALS, INC. / CIK 0000810509
Captured
SEC response SHA-256
e6e15b291454205779be87d7d17e86894a378fd299b7dd1312591814ed2d7c83

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000810509.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))